Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Schwaab

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Delaware Journal of Public Health|April 7, 2026
A Blueprint for Partnership between AI and MDThomas Schwaab, Patrick Callahan
Journal of Endourology|March 1, 2011
Editorial comment for San Francisco et alTara Kowalik, Thomas Schwaab
Expert Review of Vaccines|August 23, 2011
Provenge: combating prostate cancer with a vengeance?Thomas Schwaab, Roberto Pili
Therapy (London, England : 2004)|August 27, 2011
Therapeutic vaccines in renal cell carcinomaThomas Schwaab, Marc S Ernstoff
The New England Journal of Medicine|May 13, 2005
Images in clinical medicine. Scrotal cancerThomas Schwaab, Ajay K Nangia
Immunotherapy|October 24, 2014
High-dose IL-2 for metastatic renal cell carcinoma: can the first antitumor immunotherapy be reinvented?Jason B Muhitch, Thomas Schwaab
Reviews in Urology|January 15, 2011
Spontaneous rupture of a renal artery aneurysm presenting as gross hematuriaShaun E L Wason, Thomas Schwaab
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2012
Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancerRavi A Madan, Thomas Schwaab, James L Gulley
BJU International|December 21, 2010
RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomyMatthew H Hayn, Thomas Schwaab, Willie Underwood, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 13, 2001
Dendritic Cell Infiltration in Colon CancerThomas Schwaab, Julia E. Weiss, Alan R. Schned, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Delaware Journal of Public Health|April 7, 2026
A Blueprint for Partnership between AI and MDThomas Schwaab, Patrick Callahan
Journal of Endourology|March 1, 2011
Editorial comment for San Francisco et alTara Kowalik, Thomas Schwaab
Expert Review of Vaccines|August 23, 2011
Provenge: combating prostate cancer with a vengeance?Thomas Schwaab, Roberto Pili
Therapy (London, England : 2004)|August 27, 2011
Therapeutic vaccines in renal cell carcinomaThomas Schwaab, Marc S Ernstoff
The New England Journal of Medicine|May 13, 2005
Images in clinical medicine. Scrotal cancerThomas Schwaab, Ajay K Nangia
Immunotherapy|October 24, 2014
High-dose IL-2 for metastatic renal cell carcinoma: can the first antitumor immunotherapy be reinvented?Jason B Muhitch, Thomas Schwaab
Reviews in Urology|January 15, 2011
Spontaneous rupture of a renal artery aneurysm presenting as gross hematuriaShaun E L Wason, Thomas Schwaab
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2012
Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancerRavi A Madan, Thomas Schwaab, James L Gulley
BJU International|December 21, 2010
RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomyMatthew H Hayn, Thomas Schwaab, Willie Underwood, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 13, 2001
Dendritic Cell Infiltration in Colon CancerThomas Schwaab, Julia E. Weiss, Alan R. Schned, et al.
Pageof 5